Click here to get full coverage on Is Breathing Worse With HCM? - HealthCentral

Is Breathing Worse With HCM?  HealthCentral

Is Breathing Worse With HCM? - HealthCentral

Click here to get full coverage on Braveheart aims for freedom with IPO to support Hengrui-licensed cardio asset - Fierce Biotech

Braveheart aims for freedom with IPO to support Hengrui-licensed cardio asset  Fierce Biotech

Braveheart aims for freedom with IPO to support Hengrui-licensed cardio asset - Fierce Biotech

Click here to get full coverage on HCM Invest opens applications for pitching slots - spabusiness.com

HCM Invest opens applications for pitching slots  spabusiness.com

HCM Invest opens applications for pitching slots - spabusiness.com

Click here to get full coverage on SHaRe Registry Identifies MACE Predictors in Mild HCM - American College of Cardiology

SHaRe Registry Identifies MACE Predictors in Mild HCM  American College of Cardiology

SHaRe Registry Identifies MACE Predictors in Mild HCM - American College of Cardiology

Click here to get full coverage on A Better Idea of When Mild HCM Is Likely to Go Downhill Fast - MedPage Today

A Better Idea of When Mild HCM Is Likely to Go Downhill Fast  MedPage Today

A Better Idea of When Mild HCM Is Likely to Go Downhill Fast - MedPage Today

Click here to get full coverage on How Hypertrophic Cardiomyopathy Is Different for People of Color - Healthgrades Health Library

How Hypertrophic Cardiomyopathy Is Different for People of Color  Healthgrades Health Library

How Hypertrophic Cardiomyopathy Is Different for People of Color - Healthgrades Health Library

Click here to get full coverage on Hypertrophic Cardiomyopathy Diet: Foods to Avoid and Smart Swaps for Wellness - Everyday Health

Hypertrophic Cardiomyopathy Diet: Foods to Avoid and Smart Swaps for Wellness  Everyday Health

Hypertrophic Cardiomyopathy Diet: Foods to Avoid and Smart Swaps for Wellness - Everyday Health

Click here to get full coverage on HCM City proposes four smart parking facilities - vietnamnews.vn

HCM City proposes four smart parking facilities  vietnamnews.vn

HCM City proposes four smart parking facilities - vietnamnews.vn

Click here to get full coverage on Investigational heart drug for nonobstructive HCM one step closer to FDA approval - Cardiovascular Business

Investigational heart drug for nonobstructive HCM one step closer to FDA approval  Cardiovascular Business

Investigational heart drug for nonobstructive HCM one step closer to FDA approval - Cardiovascular Business

Click here to get full coverage on Braveheart Bio files for IPO two years after CEO sold last company for $1.2 billion - The Business Journals

Braveheart Bio files for IPO two years after CEO sold last company for $1.2 billion  The Business Journals

Braveheart Bio files for IPO two years after CEO sold last company for $1.2 billion - The Business Journals

Click here to get full coverage on Benefits of Myectomy for Obstructive HCM Are Greatest at Earlier Symptomatic Stages - Cleveland Clinic

Benefits of Myectomy for Obstructive HCM Are Greatest at Earlier Symptomatic Stages  Cleveland Clinic

Benefits of Myectomy for Obstructive HCM Are Greatest at Earlier Symptomatic Stages - Cleveland Clinic

Click here to get full coverage on Enterprise HCM Buyer Priorities: What Analysts Are Hearing From CHROs and CIOs - ADP

Enterprise HCM Buyer Priorities: What Analysts Are Hearing From CHROs and CIOs  ADP

Enterprise HCM Buyer Priorities: What Analysts Are Hearing From CHROs and CIOs - ADP

Click here to get full coverage on Indian Embassy thanks Vietnam for support after tourist boat tragedy - Asia News Network

Indian Embassy thanks Vietnam for support after tourist boat tragedy  Asia News Network

Indian Embassy thanks Vietnam for support after tourist boat tragedy - Asia News Network

Click here to get full coverage on BRVE IPO News - Cardiovascular diseases biotech Braveheart Bio files for a $100 million IPO - renaissancecapital.com

BRVE IPO News - Cardiovascular diseases biotech Braveheart Bio files for a $100 million IPO  renaissancecapital.com

BRVE IPO News - Cardiovascular diseases biotech Braveheart Bio files for a $100 million IPO - renaissancecapital.com

Click here to get full coverage on Cytokinetics Announces Positive Topline Results from ACACIA-HCM, the Pivotal Phase 3 Clinical Trial of Aficamten in Patients with Non-Obstructive Hypertrophic Cardiomyopathy - Cytokinetics

Cytokinetics Announces Positive Topline Results from ACACIA-HCM, the Pivotal Phase 3 Clinical Trial of Aficamten in Patients with Non-Obstructive Hypertrophic Cardiomyopathy  Cytokinetics

Cytokinetics Announces Positive Topline Results from ACACIA-HCM, the Pivotal Phase 3 Clinical Trial of Aficamten in Patients with Non-Obstructive Hypertrophic Cardiomyopathy - Cytokinetics

Click here to get full coverage on Buy These 3 HCM Software Solution Stocks to Tap Short-Term Potential - Yahoo Finance

Buy These 3 HCM Software Solution Stocks to Tap Short-Term Potential  Yahoo Finance

Buy These 3 HCM Software Solution Stocks to Tap Short-Term Potential - Yahoo Finance

Click here to get full coverage on Aficamten Meets Mark in Nonobstructive Hypertrophic Cardiomyopathy: ACACIA-HCM - TCTMD.com

Aficamten Meets Mark in Nonobstructive Hypertrophic Cardiomyopathy: ACACIA-HCM  TCTMD.com

Aficamten Meets Mark in Nonobstructive Hypertrophic Cardiomyopathy: ACACIA-HCM - TCTMD.com

Click here to get full coverage on Edgewise Therapeutics Announces Positive Top-Line Data from 12-Week Phase 2 CIRRUS-HCM Trial with EDG-7500 in Obstructive and Nonobstructive Hypertrophic Cardiomyopathy (HCM) - PR Newswire

Edgewise Therapeutics Announces Positive Top-Line Data from 12-Week Phase 2 CIRRUS-HCM Trial with EDG-7500 in Obstructive and Nonobstructive Hypertrophic Cardiomyopathy (HCM)  PR Newswire

Edgewise Therapeutics Announces Positive Top-Line Data from 12-Week Phase 2 CIRRUS-HCM Trial with EDG-7500 in Obstructive and Nonobstructive Hypertrophic Cardiomyopathy (HCM) - PR Newswire

Click here to get full coverage on Genotype Independently Predicts HF Outcomes in Patients With HCM - American College of Cardiology

Genotype Independently Predicts HF Outcomes in Patients With HCM  American College of Cardiology

Genotype Independently Predicts HF Outcomes in Patients With HCM - American College of Cardiology

Click here to get full coverage on What Is Aortic Dissection? A Surgeon Explains the Cause of Lindsey Graham’s Death - Everyday Health

What Is Aortic Dissection? A Surgeon Explains the Cause of Lindsey Graham’s Death  Everyday Health

What Is Aortic Dissection? A Surgeon Explains the Cause of Lindsey Graham’s Death - Everyday Health

Click here to get full coverage on GLP-1 drugs improve cardiovascular outcomes among non-obstructive HCM patients, study shows - The University of Alabama at Birmingham

GLP-1 drugs improve cardiovascular outcomes among non-obstructive HCM patients, study shows  The University of Alabama at Birmingham

GLP-1 drugs improve cardiovascular outcomes among non-obstructive HCM patients, study shows - The University of Alabama at Birmingham

Click here to get full coverage on Mavacamten in Adolescents with Obstructive Hypertrophic Cardiomyopathy - The New England Journal of Medicine

Mavacamten in Adolescents with Obstructive Hypertrophic Cardiomyopathy  The New England Journal of Medicine

Mavacamten in Adolescents with Obstructive Hypertrophic Cardiomyopathy - The New England Journal of Medicine

Click here to get full coverage on Why Hypertrophic Cardiomyopathy Symptoms Can Change From Day to Day and Over Time - Cleveland Clinic Health Essentials

Why Hypertrophic Cardiomyopathy Symptoms Can Change From Day to Day and Over Time  Cleveland Clinic Health Essentials

Why Hypertrophic Cardiomyopathy Symptoms Can Change From Day to Day and Over Time - Cleveland Clinic Health Essentials

Click here to get full coverage on Aficamten Outperforms Metoprolol Across All Phases of Exercise in Obstructive HCM - The American Journal of Managed Care® (AJMC®)

Aficamten Outperforms Metoprolol Across All Phases of Exercise in Obstructive HCM  The American Journal of Managed Care® (AJMC®)

Aficamten Outperforms Metoprolol Across All Phases of Exercise in Obstructive HCM - The American Journal of Managed Care® (AJMC®)

Click here to get full coverage on U.S. Office of Personnel Management Selects Oracle to Power Federal Workforce Modernization - Oracle

U.S. Office of Personnel Management Selects Oracle to Power Federal Workforce Modernization  Oracle

U.S. Office of Personnel Management Selects Oracle to Power Federal Workforce Modernization - Oracle

Click here to get full coverage on RASopathy Subtype Shapes Early Hypertrophic Cardiomyopathy Course, Study Finds - Bioengineer.org

RASopathy Subtype Shapes Early Hypertrophic Cardiomyopathy Course, Study Finds  Bioengineer.org

RASopathy Subtype Shapes Early Hypertrophic Cardiomyopathy Course, Study Finds - Bioengineer.org

Click here to get full coverage on 4 international exhibitions open in HCM City to showcase power, green energy, food processing technologies - vietnamnews.vn

4 international exhibitions open in HCM City to showcase power, green energy, food processing technologies  vietnamnews.vn

4 international exhibitions open in HCM City to showcase power, green energy, food processing technologies - vietnamnews.vn

Click here to get full coverage on SAP SuccessFactors Innovations Define a New Era of Autonomous HCM - SAP News Center

SAP SuccessFactors Innovations Define a New Era of Autonomous HCM  SAP News Center

SAP SuccessFactors Innovations Define a New Era of Autonomous HCM - SAP News Center

Click here to get full coverage on Edgewise reports positive top-line results from Phase II CIRRUS-HCM trial - Clinical Trials Arena

Edgewise reports positive top-line results from Phase II CIRRUS-HCM trial  Clinical Trials Arena

Edgewise reports positive top-line results from Phase II CIRRUS-HCM trial - Clinical Trials Arena

Click here to get full coverage on First-in-Human Gene Therapy for HCM Demonstrates Safety and Early Efficacy - Cleveland Clinic

First-in-Human Gene Therapy for HCM Demonstrates Safety and Early Efficacy  Cleveland Clinic

First-in-Human Gene Therapy for HCM Demonstrates Safety and Early Efficacy - Cleveland Clinic

Click here to get full coverage on Effective Stress-Reducing Techniques for HCM - HealthCentral

Effective Stress-Reducing Techniques for HCM  HealthCentral

Effective Stress-Reducing Techniques for HCM - HealthCentral

Click here to get full coverage on ACACIA-HCM: Aficamten Beats Placebo in Non-Obstructive Hypertrophic Cardiomyopathy - HCP Live

ACACIA-HCM: Aficamten Beats Placebo in Non-Obstructive Hypertrophic Cardiomyopathy  HCP Live

ACACIA-HCM: Aficamten Beats Placebo in Non-Obstructive Hypertrophic Cardiomyopathy - HCP Live

Click here to get full coverage on Cytokinetics Announces New Data Related to MYQORZO® (aficamten) at ESC Heart Failure 2026 - Cytokinetics

Cytokinetics Announces New Data Related to MYQORZO® (aficamten) at ESC Heart Failure 2026  Cytokinetics

Cytokinetics Announces New Data Related to MYQORZO® (aficamten) at ESC Heart Failure 2026 - Cytokinetics

Click here to get full coverage on HCM City proposes cutting power, water for illegal buildings - DTiNews

HCM City proposes cutting power, water for illegal buildings  DTiNews

HCM City proposes cutting power, water for illegal buildings - DTiNews

Click here to get full coverage on PeopleSoft HCM Update Image 55: Helping Organizations Work Smarter, Recognize Employees, and Improve HR Operations - Oracle Blogs

PeopleSoft HCM Update Image 55: Helping Organizations Work Smarter, Recognize Employees, and Improve HR Operations  Oracle Blogs

PeopleSoft HCM Update Image 55: Helping Organizations Work Smarter, Recognize Employees, and Improve HR Operations - Oracle Blogs

Click here to get full coverage on CMR Imaging, NT-proBNP Improve Risk Prediction in Hypertrophic Cardiomyopathy - The American Journal of Managed Care® (AJMC®)

CMR Imaging, NT-proBNP Improve Risk Prediction in Hypertrophic Cardiomyopathy  The American Journal of Managed Care® (AJMC®)

CMR Imaging, NT-proBNP Improve Risk Prediction in Hypertrophic Cardiomyopathy - The American Journal of Managed Care® (AJMC®)

Click here to get full coverage on 7 Supplements to Avoid With Obstructive Hypertrophic Cardiomyopathy - Everyday Health

7 Supplements to Avoid With Obstructive Hypertrophic Cardiomyopathy  Everyday Health

7 Supplements to Avoid With Obstructive Hypertrophic Cardiomyopathy - Everyday Health

Click here to get full coverage on Major Heart Study to Improve Care for Hypertrophic Cardiomyopathy - UVA Health

Major Heart Study to Improve Care for Hypertrophic Cardiomyopathy  UVA Health

Major Heart Study to Improve Care for Hypertrophic Cardiomyopathy - UVA Health

Click here to get full coverage on Learning Path for VB Express, Business Rules & Redwood Personalization - Oracle Blogs

Learning Path for VB Express, Business Rules & Redwood Personalization  Oracle Blogs

Learning Path for VB Express, Business Rules & Redwood Personalization - Oracle Blogs

Click here to get full coverage on Prognostic Impact of LGE Granularity Using CMR in End‑Stage Hypertrophic Cardiomyopathy - American Heart Association Journals

Prognostic Impact of LGE Granularity Using CMR in End‑Stage Hypertrophic Cardiomyopathy  American Heart Association Journals

Prognostic Impact of LGE Granularity Using CMR in End‑Stage Hypertrophic Cardiomyopathy - American Heart Association Journals

Click here to get full coverage on Nonobstructive HCM Treatment: Differential Effect of Bisoprolol vs. Verapamil - American College of Cardiology

Nonobstructive HCM Treatment: Differential Effect of Bisoprolol vs. Verapamil  American College of Cardiology

Nonobstructive HCM Treatment: Differential Effect of Bisoprolol vs. Verapamil - American College of Cardiology

Click here to get full coverage on The Importance of Early Diagnosis and Treatment in Obstructive HCM - HCP Live

The Importance of Early Diagnosis and Treatment in Obstructive HCM  HCP Live

The Importance of Early Diagnosis and Treatment in Obstructive HCM - HCP Live

Click here to get full coverage on SCOUT-HCM: Mavacamten Can Benefit Teens With Obstructive HCM, Too - TCTMD.com

SCOUT-HCM: Mavacamten Can Benefit Teens With Obstructive HCM, Too  TCTMD.com

SCOUT-HCM: Mavacamten Can Benefit Teens With Obstructive HCM, Too - TCTMD.com

Click here to get full coverage on PeopleSoft Aligns HCM and FSCM Update Cadence with Customer Adoption Starting in 2027 - Oracle Blogs

PeopleSoft Aligns HCM and FSCM Update Cadence with Customer Adoption Starting in 2027  Oracle Blogs

PeopleSoft Aligns HCM and FSCM Update Cadence with Customer Adoption Starting in 2027 - Oracle Blogs

Click here to get full coverage on Phase 3 HCM Drug Offers Promising Results in Exercise Tests - Medscape

Phase 3 HCM Drug Offers Promising Results in Exercise Tests  Medscape

Phase 3 HCM Drug Offers Promising Results in Exercise Tests - Medscape

Click here to get full coverage on Mavacamten Shows Landmark Success in Adolescent Obstructive HCM - Pharmacy Times

Mavacamten Shows Landmark Success in Adolescent Obstructive HCM  Pharmacy Times

Mavacamten Shows Landmark Success in Adolescent Obstructive HCM - Pharmacy Times

Click here to get full coverage on Indian national to stand trial in HCM City over alleged diamond smuggling ring - The Star

Indian national to stand trial in HCM City over alleged diamond smuggling ring  The Star

Indian national to stand trial in HCM City over alleged diamond smuggling ring - The Star

Click here to get full coverage on Aficamten Demonstrates Efficacy in Nonobstructive HCM, Meeting Both Primary End Points in Phase 3 Trial - Pharmacy Times

Aficamten Demonstrates Efficacy in Nonobstructive HCM, Meeting Both Primary End Points in Phase 3 Trial  Pharmacy Times

Aficamten Demonstrates Efficacy in Nonobstructive HCM, Meeting Both Primary End Points in Phase 3 Trial - Pharmacy Times

Click here to get full coverage on SCOUT-HCM: Mavacamten Outperforms Placebo in Adolescents With HCM, With Joseph Rossano, MD, MS - HCP Live

SCOUT-HCM: Mavacamten Outperforms Placebo in Adolescents With HCM, With Joseph Rossano, MD, MS  HCP Live

SCOUT-HCM: Mavacamten Outperforms Placebo in Adolescents With HCM, With Joseph Rossano, MD, MS - HCP Live

Click here to get full coverage on 8 Best HCM Software Companies - Paycor

8 Best HCM Software Companies - Paycor

Click here to get full coverage on Differences in Disease Trajectory, Comorbidities, and Mortality in Sarcomeric and Nonsarcomeric Hypertrophic Cardiomyopathy - American Heart Association Journals

Differences in Disease Trajectory, Comorbidities, and Mortality in Sarcomeric and Nonsarcomeric Hypertrophic Cardiomyopathy  American Heart Association Journals

Differences in Disease Trajectory, Comorbidities, and Mortality in Sarcomeric and Nonsarcomeric Hypertrophic Cardiomyopathy - American Heart Association Journals

Click here to get full coverage on Biobank-Scale Plasma Proteomics Identifies Novel Biomarkers in Hypertrophic Cardiomyopathy - American Heart Association Journals

Biobank-Scale Plasma Proteomics Identifies Novel Biomarkers in Hypertrophic Cardiomyopathy  American Heart Association Journals

Biobank-Scale Plasma Proteomics Identifies Novel Biomarkers in Hypertrophic Cardiomyopathy - American Heart Association Journals

Click here to get full coverage on Mavacamten Shows Benefit for Pediatric Patients in SCOUT-HCM Trial - HCP Live

Mavacamten Shows Benefit for Pediatric Patients in SCOUT-HCM Trial  HCP Live

Mavacamten Shows Benefit for Pediatric Patients in SCOUT-HCM Trial - HCP Live

Click here to get full coverage on Is Progression of Myocardial Fibrosis a Risk Indicator in HCM? - American College of Cardiology

Is Progression of Myocardial Fibrosis a Risk Indicator in HCM?  American College of Cardiology

Is Progression of Myocardial Fibrosis a Risk Indicator in HCM? - American College of Cardiology

Click here to get full coverage on Mavacamten in Adolescents with Obstructive HCM: Expert Insights From Joseph Rossano - Pharmacy Times

Mavacamten in Adolescents with Obstructive HCM: Expert Insights From Joseph Rossano  Pharmacy Times

Mavacamten in Adolescents with Obstructive HCM: Expert Insights From Joseph Rossano - Pharmacy Times

Click here to get full coverage on HCM City launches AI platform to streamline investment promotion - vietnamnews.vn

HCM City launches AI platform to streamline investment promotion  vietnamnews.vn

HCM City launches AI platform to streamline investment promotion - vietnamnews.vn

Click here to get full coverage on CRLF1 Secreted by Cardiac Fibroblasts Promotes Human Hypertrophic Cardiomyopathy - American Heart Association Journals

CRLF1 Secreted by Cardiac Fibroblasts Promotes Human Hypertrophic Cardiomyopathy  American Heart Association Journals

CRLF1 Secreted by Cardiac Fibroblasts Promotes Human Hypertrophic Cardiomyopathy - American Heart Association Journals

Click here to get full coverage on Nucleus named ADP Lyric HCM a leader in its Enterprise HCM Value Matrix 2026 evaluation - ADP

Nucleus named ADP Lyric HCM a leader in its Enterprise HCM Value Matrix 2026 evaluation  ADP

Nucleus named ADP Lyric HCM a leader in its Enterprise HCM Value Matrix 2026 evaluation - ADP

Click here to get full coverage on RoMa : A Cardiopulmonary Exercise Testing Based Risk Tool in Hypertrophic Cardiomyopathy - American Heart Association Journals

RoMa : A Cardiopulmonary Exercise Testing Based Risk Tool in Hypertrophic Cardiomyopathy  American Heart Association Journals

RoMa : A Cardiopulmonary Exercise Testing Based Risk Tool in Hypertrophic Cardiomyopathy - American Heart Association Journals

Click here to get full coverage on 12 Drugs to Avoid if You Have Obstructive Hypertrophic Cardiomyopathy - Everyday Health

12 Drugs to Avoid if You Have Obstructive Hypertrophic Cardiomyopathy  Everyday Health

12 Drugs to Avoid if You Have Obstructive Hypertrophic Cardiomyopathy - Everyday Health

Click here to get full coverage on Ho Chi Minh City opens Digital Citizen Station offering free healthcare services - Tuoi Tre News | The News Gateway to Vietnam

Ho Chi Minh City opens Digital Citizen Station offering free healthcare services  Tuoi Tre News | The News Gateway to Vietnam

Ho Chi Minh City opens Digital Citizen Station offering free healthcare services - Tuoi Tre News | The News Gateway to Vietnam

Click here to get full coverage on International study shows mavacamten monotherapy improves heart function in patients with HCM, a common inherited heart disease | UAB News - The University of Alabama at Birmingham

International study shows mavacamten monotherapy improves heart function in patients with HCM, a common inherited heart disease | UAB News  The University of Alabama at Birmingham

International study shows mavacamten monotherapy improves heart function in patients with HCM, a common inherited heart disease | UAB News - The University of Alabama at Birmingham

Click here to get full coverage on Ho Chi Minh city Air Quality Index (AQI) and Vietnam Air Pollution - IQAir

Ho Chi Minh city Air Quality Index (AQI) and Vietnam Air Pollution  IQAir

Ho Chi Minh city Air Quality Index (AQI) and Vietnam Air Pollution - IQAir

Click here to get full coverage on Cats with obstructive HCM: Can carvedilol at a higher dose improve clinical symptoms? - DVM360

Cats with obstructive HCM: Can carvedilol at a higher dose improve clinical symptoms?  DVM360

Cats with obstructive HCM: Can carvedilol at a higher dose improve clinical symptoms? - DVM360

Click here to get full coverage on Cytokinetics to Announce Topline Results from ACACIA-HCM, the Pivotal Phase 3 Clinical Trial of Aficamten in Patients with Non-Obstructive Hypertrophic Cardiomyopathy, on May 5, 2026 - GlobeNewswire

Cytokinetics to Announce Topline Results from ACACIA-HCM, the Pivotal Phase 3 Clinical Trial of Aficamten in Patients with Non-Obstructive Hypertrophic Cardiomyopathy, on May 5, 2026  GlobeNewswire

Cytokinetics to Announce Topline Results from ACACIA-HCM, the Pivotal Phase 3 Clinical Trial of Aficamten in Patients with Non-Obstructive Hypertrophic Cardiomyopathy, on May 5, 2026 - GlobeNewswire

Click here to get full coverage on What’s Next in Obstructive Hypertrophic Cardiomyopathy Treatment? - Everyday Health

What’s Next in Obstructive Hypertrophic Cardiomyopathy Treatment?  Everyday Health

What’s Next in Obstructive Hypertrophic Cardiomyopathy Treatment? - Everyday Health

Click here to get full coverage on Aficamten, ACACIA-HCM, and the Road to the First nHCM Drug - Cardiac Wire

Aficamten, ACACIA-HCM, and the Road to the First nHCM Drug  Cardiac Wire

Aficamten, ACACIA-HCM, and the Road to the First nHCM Drug - Cardiac Wire

Click here to get full coverage on Why HUTCHMED (China) Limited (HCM) Is Gaining Attention After China Biotech Re-Rating - Yahoo Finance

Why HUTCHMED (China) Limited (HCM) Is Gaining Attention After China Biotech Re-Rating  Yahoo Finance

HCM

Price Chart

Key Statistics

Technicals

About HCM

Latest News

Is Breathing Worse With HCM? - HealthCentral

Braveheart aims for freedom with IPO to support Hengrui-licensed cardio asset - Fierce Biotech

HCM Invest opens applications for pitching slots - spabusiness.com

Advanced Charts

Top Gainers

Top Losers